List view / Grid view

U.S. Pharmacopeial Convention

Filter the results

 

article

Current activities of the USP Microbiology Expert Committee

18 April 2013 | By Radhakrishna S. Tirumalai

For sterile as well as nonsterile pharmaceutical products, manufacturers must eliminate or minimise potential risks to patients as well as product quality. While many contributing factors may affect the quality of a medicine or its ingredients, microbial contamination control and proper sterilisation methods are critical considerations for the manufacturer throughout…